Humankind Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.36M | Buy |
18,084
+2,893
| +19% | +$537K | 0.82% | 19 |
|
|
2025
Q1 | $3.18M | Sell |
15,191
-3,132
| -17% | -$656K | 0.83% | 17 |
|
|
2024
Q4 | $3.26M | Buy |
18,323
+3,316
| +22% | +$589K | 0.82% | 19 |
|
|
2024
Q3 | $2.96M | Sell |
15,007
-1,292
| -8% | -$255K | 1.07% | 14 |
|
|
2024
Q2 | $2.8M | Buy |
16,299
+2,182
| +15% | +$374K | 0.74% | 20 |
|
|
2024
Q1 | $2.57M | Sell |
14,117
-2,575
| -15% | -$469K | 0.68% | 28 |
|
|
2023
Q4 | $2.59M | Buy |
16,692
+1,205
| +8% | +$187K | 0.77% | 22 |
|
|
2023
Q3 | $2.31M | Sell |
15,487
-617
| -4% | -$92K | 0.96% | 16 |
|
|
2023
Q2 | $2.17M | Buy |
16,104
+1,715
| +12% | +$231K | 0.85% | 19 |
|
|
2023
Q1 | $2.29M | Buy |
14,389
+491
| +4% | +$78.3K | 0.95% | 16 |
|
|
2022
Q4 | $2.25M | Sell |
13,898
-1,321
| -9% | -$213K | 0.97% | 16 |
|
|
2022
Q3 | $2.04M | Buy |
15,219
+3,168
| +26% | +$425K | 0.99% | 18 |
|
|
2022
Q2 | $1.85M | Buy |
12,051
+1,190
| +11% | +$182K | 0.88% | 17 |
|
|
2022
Q1 | $1.76M | Sell |
10,861
-2,088
| -16% | -$339K | 0.72% | 22 |
|
|
2021
Q4 | $1.75M | Buy |
12,949
+1,560
| +14% | +$211K | 2.21% | 11 |
|
|
2021
Q3 | $1.23M | Buy |
11,389
+2,282
| +25% | +$246K | 1.87% | 12 |
|
|
2021
Q2 | $1.03M | Buy |
9,107
+3,146
| +53% | +$354K | 1.83% | 16 |
|
|
2021
Q1 | $645K | Buy |
+5,961
| New | +$645K | 1.98% | 18 |
|